Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17777793 | 0.81 | CA12 (0.37) | EGFR | |
| SCHEMBL2190725 | 0.77 | EGFR (0.40) | EGFRPAX8 | |
| SCHEMBL9319960 | 0.76 | EGFR (0.39) | EGFRPAX8 | |
| SCHEMBL19442312 | 0.76 | EGFR (0.39) | EGFRPAX8 | |
| SCHEMBL7868646 | 0.74 | NPC1 (0.40) | EGFRPAX8 | |
| SCHEMBL7166020 | 0.74 | LMNA (0.35) | — | |
| SCHEMBL5965047 | 0.73 | EGFR (0.37) | EGFRPAX8 | |
| SCHEMBL1082715 | 0.73 | TSHR (0.39) | EGFRPAX8 | |
| SCHEMBL25144748 | 0.72 | — | — | |
| SCHEMBL5673103 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017012963-A1 | POLYMERIZABLE FATTY ACID-DERIVATIVE-MONOMERS WITH TERMINAL OLEFINIC DOUBLE BONDS, POLYMERS CONTAINING SAME MONOMERS, PRODUCTION AND USE THEREOF | BASF SE (DE) | 2017-01-26 | — | — | WO | claimed |
| EP-4355798-A1 | BIODEGRADABLE GRAFT POLYMERS | BASF SE (DE) | 2024-04-24 | — | — | EP | disclosed |
| WO-2022263354-A1 | BIODEGRADABLE GRAFT POLYMERS | BASF SE (DE) | 2022-12-22 | — | — | WO | disclosed |
| EP-2342079-B1 | USE OF COMPOSITE FILMS AS A PACKAGING MATERIAL FOR OXIDATION-SENSITIVE POLYMERS, METHOD FOR PACKAGING OXIDATION-SENSITIVE POLYMERS, AND PACKAGING FORMS CONTAINING SAID COMPOSITE FILMS | BASF SE (DE) | 2018-06-20 | — | — | EP | disclosed |
| US-9982074-B2 | Use of composite films as a packaging material for oxidation-sensitive polymers, method for packaging oxidation-sensitive polymers, and packaging containing said composite films | BASF SE (DE) | 2018-05-29 | — | — | US | disclosed |
| US-9783524-B2 | Protein tyrosine kinase modulators and methods of use | BETTA PHARMACEUTICALS CO., LTD. (CN) | 2017-10-10 | — | — | US | disclosed |
| WO-2017012963-A1 | POLYMERIZABLE FATTY ACID-DERIVATIVE-MONOMERS WITH TERMINAL OLEFINIC DOUBLE BONDS, POLYMERS CONTAINING SAME MONOMERS, PRODUCTION AND USE THEREOF | BASF SE (DE) | 2017-01-26 | — | — | WO | disclosed |
| US-20160145237-A1 | PROTEIN TYROSINE KINASE MODULATORS AND METHODS OF USE | BETTA PHARMACEUTICALS CO., LTD (CN) | 2016-05-26 | — | — | US | disclosed |
| US-20110257339-A1 | METHOD FOR STABILIZING POLYMERS | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| US-20110220534-A1 | USE OF COMPOSITE FILMS AS A PACKAGING MATERIAL FOR OXIDATION-SENSITIVE POLYMERS, METHOD FOR PACKAGING OXIDATION-SENSITIVE POLYMERS, AND PACKAGING CONTAINING SAID COMPOSITE FILMS | BASF SE (DE) | 2011-09-15 | — | — | US | disclosed |
| EP-2342079-A1 | USE OF COMPOSITE FILMS AS A PACKAGING MATERIAL FOR OXIDATION-SENSITIVE POLYMERS, METHOD FOR PACKAGING OXIDATION-SENSITIVE POLYMERS, AND PACKAGING FORMS CONTAINING SAID COMPOSITE FILMS | BASF SE (DE) | 2011-07-13 | — | — | EP | disclosed |
| WO-2010072640-A9 | METHOD FOR STABILIZING POLYMERS | BASF SE (DE) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010072640-A1 | METHOD FOR STABILIZING POLYMERS | BASF SE (DE) | 2010-07-01 | — | — | WO | disclosed |
| WO-2010052088-A1 | USE OF COMPOSITE FILMS AS A PACKAGING MATERIAL FOR OXIDATION-SENSITIVE POLYMERS, METHOD FOR PACKAGING OXIDATION-SENSITIVE POLYMERS, AND PACKAGING FORMS CONTAINING SAID COMPOSITE FILMS | BASF SE (DE) | 2010-05-14 | — | — | WO | disclosed |
| US-20080200433-A1 | Molecular Chaperone Function Regulator | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20080200433-A1 | Molecular Chaperone Function Regulator | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20070265260-A1 | Quinazoline derivatives | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-11-15 | — | — | US | disclosed |
| US-20070265260-A1 | Quinazoline derivatives | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-11-15 | — | — | US | disclosed |
| US-7294629-B2 | Quinazoline derivatives | MITSUBISHI PHARMA CORPORATION (JP) | 2007-11-13 | — | — | US | disclosed |
| US-7294629-B2 | Quinazoline derivatives | MITSUBISHI PHARMA CORPORATION (JP) | 2007-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145237-A1 | PROTEIN TYROSINE KINASE MODULATORS AND METHODS OF USE | ALK, EGFR, ERBB2 | EGFR 2/4885PAX8 4096/4885 |
| US-20070265260-A1 | Quinazoline derivatives | TYK2, ROR1, JAK1 | EGFR 1535/4885PAX8 2006/4885 |
| US-20080200433-A1 | Molecular Chaperone Function Regulator | HSPBP1, HSF1, HSPH1 | EGFR 4772/4885PAX8 3337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.